Camille Audousset
YOU?
Author Swipe
View article: Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR
Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR Open
Rationale Respiratory status of people with Cystic Fibrosis (pwCF) carrying N1303K is improved by Elexacaftor/Tezacaftor/Ivacaftor (ETI) but, contrary to other mutations, the impact on sweat test results is limited. Methods To explore this…
View article: Pregnancy and neonatal outcome following in utero exposure to CFTR modulators: A multicentre prospective case series
Pregnancy and neonatal outcome following in utero exposure to CFTR modulators: A multicentre prospective case series Open
This prospective case series - the largest to date - does not suggest a high rate of MCA or neonatal adverse outcomes in CFTRm-exposed pregnancies. Further studies including long-term follow-up of in utero exposed children are needed to co…
View article: Preliminary proposals for the follow-up of infants born to mothers with cystic fibrosis treated with CFTR modulators during the first two years of life
Preliminary proposals for the follow-up of infants born to mothers with cystic fibrosis treated with CFTR modulators during the first two years of life Open
The number of pregnancies in women with cystic fibrosis (CF) has significantly increased in recent years, leading to a corresponding rise in the number of healthy infants exposed to cystic fibrosis transmembrane conductance regulator modul…
View article: Cystic fibrosis: influence of CFTR variants on epididymal sperm recovery and ICSI results
Cystic fibrosis: influence of CFTR variants on epididymal sperm recovery and ICSI results Open
Cystic fibrosis patients exhibit poorer MESA outcomes than CFTR-RD patients, with the absence of residual CFTR activity significantly affecting the results. Cumulative ICSI outcomes were highly favourable for cystic fibrosis patients, show…
View article: The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study
The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study Open
View article: Beyond Kaftrio : mechanistic insights to maximize N1303K-CFTR rescue
Beyond Kaftrio : mechanistic insights to maximize N1303K-CFTR rescue Open
Introduction N1303K is the fourth most frequent Cystic Fibrosis (CF) causing mutation. People with CF (pwCF) clinical status can be improved by Elexacaftor(ELX)/Tezacaftor(TEZ)/Ivacaftor (ETI) combotherapy. We investigated the mechanism un…
View article: Mucus plugs in the airways of asthmatic subjects and smoking status
Mucus plugs in the airways of asthmatic subjects and smoking status Open
View article: P336 Evolution of the body composition of people with cystic fibrosis 6 months after the introduction of treatment with exacaftor/tezacaftor/ivacaftor (ETI)
P336 Evolution of the body composition of people with cystic fibrosis 6 months after the introduction of treatment with exacaftor/tezacaftor/ivacaftor (ETI) Open
View article: NOD-like receptors in asthma
NOD-like receptors in asthma Open
Asthma is an extremely prevalent chronic inflammatory disease of the airway where innate and adaptive immune systems participate collectively with epithelial and other structural cells to cause airway hyperresponsiveness, mucus overproduct…
View article: Involvement of the NOD1 receptor in allergic asthma to dust mites & Functional impact of mucus plugs in the airways of severe asthma patients according to their smoking status
Involvement of the NOD1 receptor in allergic asthma to dust mites & Functional impact of mucus plugs in the airways of severe asthma patients according to their smoking status Open
L’asthme est une maladie inflammatoire chronique des voies aériennesresponsable d’une morbi-mortalité significative et définie par une association entre dessymptômes cliniques et une obstruction bronchique variable. Les caractéristiques ca…
View article: Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches – Pulmonary Disease/Asthma
Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches – Pulmonary Disease/Asthma Open
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a major transcription factor involved in redox homeostasis and in the response induced by oxidative injury. Nrf2 is present in an inactive state in the cytoplasm of cells. Its activatio…
View article: NOD1 sensing of house dust mite–derived microbiota promotes allergic experimental asthma
NOD1 sensing of house dust mite–derived microbiota promotes allergic experimental asthma Open
View article: P117 Time course of pulmonary hyperinflation in adult cystic fibrosis: clinical and lung function correlates
P117 Time course of pulmonary hyperinflation in adult cystic fibrosis: clinical and lung function correlates Open
View article: Innate lymphoid cells at the interface between obesity and asthma
Innate lymphoid cells at the interface between obesity and asthma Open
Summary Obesity and asthma prevalence has dramatically and concomitantly increased over the last 25 years, and many epidemiological studies have highlighted obesity as an important risk factor for asthma. Although many studies have been pe…